Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-18

Clinical Trial Update: Treatment of Tendon Injury Using Mesenchymal Stem Cells [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating mesenchymal stem cells for treating lateral epicondylitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Lateral Epicondylitis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2022-02-18